DUBLIN, July 18, 2018 /PRNewswire/ -- United Neuroscience, Ltd., (UNS), a clinical stage biotech company focused on the treatmentof Alzheimer's, announced today that the company will present at the upcoming Alzheimer's Association International Conference (AAIC) being held July 22-26, 2018, in Chicago. AAIC is the
"At United Neuroscience, we envision a world where vaccines are used to treat and ultimately prevent Alzheimer's," said Ajay Verma, M.D., Ph.D., CMO of United Neuroscience. "We have built a robust translational platform to rapidly design and develop targeted immunotherapeutics based on the industry's leading endobody vaccine technology. Our presence at AAIC this year demonstrates our commitment to transforming the lives of all patients and families affected by Alzheimer's."
Poster Presentation Details:
Title: Baseline Characteristics for Patients with Mild Alzheimer's Disease Enrolled in the Phase IIa Trial of Active Immunotherapeutic Vaccine UB-311Date: July 22, 2018 Time: 9:30 am – 4:15 pm CDT Location: Hall - F1, McCormick Place, Chicago Abstract Number: P1-037
The Alzheimer's Association International Conference® (AAIC®) is the largest and most influential international meeting dedicated to advancing dementia science. The Conference assembles the world's leading researchers, clinicians and the care research community to communicate discoveries that will lead to methods of prevention and treatment for Alzheimer's disease. For more information about AAIC, please visit www.alz.org/aaic.
About United Neuroscience
United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of best-in-class immunotherapeutics for the brain. A global company headquartered in Dublin, Ireland, with operations in Taiwan and the United States, UNS was founded to address the social and economic burden of Alzheimer's and other neurodegenerative diseases and seeks to rapidly advance candidates into and through clinical trials with the goal of delivering breakthrough treatments to patients. For more information please visit www.unitedneuroscience.com. Follow UNS on Twitter at https://twitter.com/UNSTechBio and on LinkedIn at https://www.linkedin.com/company/unitedneuroscience.
David Schull or Brittanie DoughertyRusso Partners, LLC(212) 845-4271(646) firstname.lastname@example.org email@example.com
View original content:http://www.prnewswire.com/news-releases/united-neuroscience-announces-presentation-at-the-2018-alzheimers-association-international-conference-aaic-300682981.html
SOURCE United Neuroscience, Ltd.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All